Indoleamine 2,3-dioxygenase (IDO) plays multiple roles in tumor activation, including inhibiting T cells and NK cells, promoting the activity of Tregs and myeloid-derived suppressor cells, and stimulating tumor angiogenesis (Prendergast et al., 2014; Meireson et al., 2020). Here, IDO2 is linked to neoplasm.